Differences in antiretroviral regimens do not impact safety or level of latency reversal in persons receiving romidepsin.Sofie Jørgensen,Steffen Leth,Maja Sommerfelt,Lars Østergaard,Martin Tolstrup,Ole S SøgaardAIDS(2018)引用 1|浏览14暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要